FDA Investigator Edwin Melendez

Edwin Melendez has inspections in 14 countries as of 16 Jun 2023. Edwin Melendez has collaborated with a combinined 4894 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
33
Last Inspection Date:
16 Jun 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United Kingdom of Great Britain and Northern Ireland, Ireland, Israel, Belgium, United States of America, China, Singapore, India, Spain, Portugal, Mexico, Italy, Sweden
Co-Investigator(s):
Ademola O Daramola, Alexander M Kay, Amir Alavi, Anastasia M Shields, Andria L Kuhlman, Angela E Glenn, Anissa M Cheung, Anissa M Vargas, Anita Narula, PhD, Anita R Michael, Anthony A Charity, Ashar P Parikh, Astrida B Mattson, Azza Talaat, Bapu R Gaddam, Barbara Janine Breithaupt, Barbara M Frazier, Bernice F Hirsch, Bonita S Chester, Bradley Dworak, PhD, Brooke K Higgins, Brooke K Seeman, Bruce H Mccullough, Burnell M Henry, Carla J Lundi, Carole L Jones, Caryn M Mcnab, Catherine J Laufmann, CDR Rochelle B Young, RPh, MSA, Charisse K Green, Charles I Ann, Charles R Cote, RIC, Christian D Lynch (CDL), Christine A Harman, PhD, Christopher S Keating, Chryste D Best, Colleen F Hoyt, Concepcion Cruz, Jr, Connie P Rezendes, Connie P Rezenes, Connie R Kiessling, Constance Y Fears, Corey K Reno, Cynthia J Lee, MS, Dandan Wang, PhD, Daniel R Tammariello, David J Hafner, David K Lau, David M Beltran, Dawn E Barkans, Deborah A Greco, Debra L Pagano, Dell S Moller, Denise M Digiulio, Dennis Cantellops Paite, Diane T Bargo, Diane T O'brien, Dipesh K Shah, Dolores E Price, Don H Bark, PhD, Dr. Guang Gao, PhD, Eileen A Liu, Elizabeth Ll Edwards, Emest F Bizjak, Farhana Khan, Felix Maldonado, Francis A Guidry, George R Smith, George Smith, Gerald B Seaborn, Jr, Gerard Pde Leon, Gerardo Z Vazquez, German Rivera, Gloria E Parra, Gloria J Baca, MS, Gwyn G Dickinson, Haitao Li, Hasan A Irier, PhD, Heika R Bounds, Heika R Tait, Heriberto Negron Rivera, Ivis Lnegron Torres, Jacqueline Mdiaz Albertini, James C Maclaughlin, Janete F Guardia, Jeffery A Hangartner, Jeffrey P Raimondi, Jennifer L Bridgewater, Jennifer L Gustavus, Jennifer M Gogley, Jocelyn E Massey, Joey V Quitania, Jonah S Ufferfilge, Jonathan G Matrisciano, Jonathan W Chapman, Jonee J Mearns, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose M Cayuela, Jose R Hernandez, Joseph J Vannelli, Joshua P Wireman, Julianne C Mccullough, Junho Pak, Justin A Boyd, Kari M Johansen, Karl D Hezel, Katherine Szestypalow, Kathryn A Krentz, Katie L Penno, Kellia N Hicks, Kenneth O Gee, PhD, Kent C Faul, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kristen D Evans, Kristin M Abaonza, Kumar G Janoria, Langer, Larry K Austin, Laura Fontan, MS, Laurel A Beer, Laurissa S Flowers, LCDR Anastasia Mpiliafas Brown, LCDR Debra Emerson, Leonard H Lavi, Lequita M Mayhew, Lewis K Antwi, Li Hongpaul Yeh, PhD, Libia M Lugo, Linda R Kuchenthal, Linda Thai, Lindsey M Schwierjohann, Lisa Hayka, Lisa K Capron, Lisa M Bellows, Lori S Lawless, Luis A Dasta, Luis M Burgos Medero, Lynda L Perry, PhD, Marcellinus D Dordunoo, Margaret A Smithers, Margaret M Annes, Margarita Santiago, Maria Pkelly Doggett, MBA, Marie F Morin, Marijo B Kambere, PhD, Marion Michaelis, Mariza M Jafary, Mark W Babbitt, Marvin D Jones, Marybet Lopez, Matthew B Casale, Maxine H Wong, Maya M Davis, Megan A Haggerty, Meisha R Sampson, Meisha Waters, Melissa D Ray, Melissa J Garcia, Merideth K Rose, Michael A Taylor, Michael E Maselli, Michael L Casner, Michael R Goga, Michele L Obert, Miguel A Martinez, Mihaly S Ligmond, Mikel T Wright, Mohsen Rajabi Abhari, FDA, Mra B Kamberem, Mra Davism, Mra Mcculloughj, Mra Munizn, Mra Narulaa, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy F Scheraga, Nancy L Rolli, Nebil A Oumer, Nerizza B Guerin, Nicholas A Violand, Nicole E Knowlton, Noreen Muniz, Norma Wong, Norman Wong, Omotunde O Osunsanmi, Parul M Patel, Patricia A Mcilroy, Patricia A Morrow, Patricia D Stahnke, Patrick C Klotzbuecher, Paul A Bonneau, Paul L Figarole, Jr, Paula A Trost, Peter E Baker, Philip F Istafanos, DMV, MS, Prabhu P Raju, Rachael A Moliver, Rachel C Harrington, Rafael E Arroyo, Ralph A Erickson, Ralph H Vocque, Randy L Self, Raquel Gonzalez Rivera, Rebecca Rodriguez, Robert D Tollefsen, Robert J Martin, Robert M Barbosa, Robert R Wilson, Rochelle K Kimmel, Rose Xu, Rozelle G Smith, S Lori Brown, PhD MPH, Salvatore N Randazzo, Samantha J Bradley, Sandra A Hughes, Sangeeta M Khurana, PhD, Sangeeta M Rataul, Satheesh Thomas, Scott T Ballard, Seneca D Toms, Sharon K Thoma, PharmD, Shirley J Berryman, Shirshendu K Deb, PhD, Shusheen A Alexander, Simone E Pitts, Steven A Gonzales, Steven C Madzo, Steven M Weinman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susant Hadman, Suzanne M Healy, Suzanne M Muchene, Tajah L Blackburn, Ted L Anderson, Terri L Dodds, Terry L Dodds, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy T Kapsala, Tina S Roecklein, Tracey L Harris, Tracy K Li, Unnee Ranjan, Uttaniti Limchumroon (Tom), Vien Q Le, Vipulchandr N Dholakia, Virgilio F Pacio, CSO, Vlada Matusovsky, Wayne E Seifert, William J Leonard, Xiaokuang Lai, PhD, Xiomara Copeland, Yumi J Hiramine, Yvesna C Blaise, Yvette I Johnson, Yvins Dezan, Zachary A Bogorad, Zachary L Miller, Zhong Li, PhD, Zhongren Wu, Zi Qiang Gu

Edwin Melendez's Documents

Publish Date Document Type Title
November, 2003 FDA 483 Norton Healthcare Limited - Form 483, 2003-11-04
January, 2008 FDA 483 Response Fresenius Kabi AB - Form 483R, 2008-02-20
May, 2005 FDA 483 Glaxo Operations UK Ltd - Form 483, 2005-05-03
January, 2008 FDA 483 Fresenius Kabi AB - Form 483, 2008-01-30
May, 2005 FDA 483 Response EUMEDICA PHARMACEUTICALS INDUSTRIES SOCIEDAD LIMITADA - Form 483R, 2005-07-27
October, 2005 EIR Saraca Laboratories Limited - EIR, 2005-10-19
May, 2009 FDA 483 Jubilant HollisterStier LLC - Form 483, 2009-05-08
May, 2005 EIR EUMEDICA PHARMACEUTICALS INDUSTRIES SOCIEDAD LIMITADA - EIR, 2005-05-17
May, 2005 FDA 483 Response Glaxo Operations UK Ltd - Form 483R, 2005-05-17
March, 2004 FDA 483 HIKMA FARMACEUTICA (PORTUGAL), S.A - Form 483, 2004-03-31
March, 2003 FDA 483 DR. REDDY'S LABORATORIES LIMITED - Form 483, 2003-03-06
September, 2010 FDA 483 Teva Pharmaceutical Industries Ltd. - Form 483, 2010-09-16
March, 2003 EIR Dr. Reddy's Laboratories Limited (Unit II) - EIR, 2003-03-06
March, 2003 FDA 483 Response Dr. Reddy's Laboratories Limited (Unit II) - Form 483R, 2003-03-28
January, 2008 EIR Fresenius Kabi AB - EIR, 2008-01-30
August, 2006 FDA 483 Bell-More Labs Inc - Form 483, 2006-08-17
October, 2005 FDA 483 Response INDOCO REMEDIES LIMITED - Form 483R, 2005-11-21
May, 2005 EIR Eurofins Biopharma Product Testing Ireland Limited - EIR, 2005-05-06
October, 2005 EIR INDOCO REMEDIES LIMITED - EIR, 2005-10-31
October, 2005 FDA 483 INDOCO REMEDIES LIMITED - Form 483, 2005-10-31
May, 2005 FDA 483 Response Eurofins Biopharma Product Testing Ireland Limited - Form 483R, 2005-05-06
March, 2003 EIR DR. REDDY'S LABORATORIES LIMITED - EIR, 2003-03-04
October, 2006 EIR Glaxo Wellcome Manufacturing Pte. Ltd - EIR, 2006-10-26
May, 2005 EIR Glaxo Operations UK Ltd - EIR, 2005-05-03
May, 2005 FDA 483 EUMEDICA PHARMACEUTICALS INDUSTRIES SOCIEDAD LIMITADA - Form 483, 2005-05-16
March, 2003 FDA 483 Response DR. REDDY'S LABORATORIES LIMITED - Form 483R, 2003-06-06

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more